Business
Appointment of interim CFO
Appointment of interim CFO.
About this update from Fusion Antibodies Plc
[{"type":"text","content":"\n\n \nFusion Antibodies plc\n(\"Fusion\" or the \"Company\")\n \nAppointment of interim CFO\n \nFusion Antibodies plc (AIM: FAB), specialists in pre-clinical antibody discovery, engineering and supply for both therapeutic drug and diagnostic applications, announces that Stephen Smyth has been appointed as interim Chief Financial Officer of the Company with immediate effect. \n \nStephen has over 25 years' experience working in audit & accounting, finance, and operations management within both the public accounting and commercial sectors. Stephen's previous roles include acting as Chief Financial Officer at Sera Global LP, as well as holding senior finance functions at Cormark Securities Inc and at PricewaterhouseCoopers (PwC) LLP. Stephen is a chartered accountant and is currently a partner at FPM, a Chartered Accountancy practice with offices throughout the Republic of Ireland and Northern Ireland, including Belfast. At FPM, he provides virtual finance function solutions to clients ranging from start-ups to private equity backed multinationals.\n \nAs part of the ongoing efforts to preserve cash, Fusion will be utilising the services of Stephen on a part-time basis, supported by a team at FPM, who will provide the Company with outsourced finance function services. It is anticipated that the Company will utilise the services of Stephen and FPM until such time that the trading recovers to levels that would support the appointment of a permanent CFO and in-house finance function. \n \nFusion Antibodies CEO, Adrian Kinkaid said: \"We are pleased to welcome Stephen on board to manage our finance team. We have been through a period of change and as we are keeping costs down, this is an ideal solution for us at the current time to conserve cash.\"\n \nAIM Disclosures\n \nStephen Barry Smyth, aged 48, is, or has been during the last five years, a director or partner of the following companies and partnerships:\n \n\n\n\nCurrent:\n\n\nPast:\n\n\n\n\nFPM Accountants Ireland Ltd\nAAB Investments Limited\n\n\nNone\n\n\n\n \nStephen does not hold any ordinary shares in the Company.\n \nEnquiries: \n \n\n\n\nFusion Antibodies plc\n\n\nwww.fusionantibodies.com\n\n\n\n\nAdrian Kinkaid, Chief Executive Officer\nRichard Buick, Chief Scientific Officer\n\n\nVia Walbro...